ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MicroRNA-217 aggravates breast cancer through activation of NF1-mediated HSF1/ATG7 axis and c-Jun/ATF3/MMP13 axis

Li, Weihan; Yang, Chaojie; Li, Jingjing; Li, Xiaolian; Zhou, Peng*广州中医药大学
Human Cell2023-1DOI: 10.1007/s13577-022-00817-y
1被引5阅读
引用收藏
分享

摘要

Application of microRNA-mediated mRNA expression in treatment of diverse cancers has been documented. The current study was explored to study the role of miR-217 in breast cancer (BC) progression and the related downstream factors. Clinical tissue samples, BC cell lines and the established xenograft models were prepared for ectopic expression and depletion experiments to discern the regulatory roles of miR-217-mediated NF1 in BC cell proliferation, metastasis and chemoresistance as well as tumorigenic ability of BC cells in nude mice. miR-217 was upregulated in BC, which was a predictor of poor prognosis of BC patients. NF1 could be targeted by miR-217. miR-217 promoted malignant characteristics of BC cells through enhancing ATF3-MMP13 interaction by inhibiting NF1. miR-217 repressed sensitivity against anti-cancer drugs by inducing autophagy of BC cells through the NF1/HSF1/ATG7 axis. Also, miR-217 could inhibit NF1 to facilitate tumorigenic ability of BC cells in vivo. Our study emphasized that miR-217 could potentially inhibit NF1 expression to activate the c-Jun, thus enhancing the expression and interaction of ATF3/MMP13 and promoting the malignant features of BC cells. Furthermore, miR-217 conferred chemoresistance on BC by enhancing BC cell autophagy, which was achieved by limiting NF1 expression to induce the HSF1/ATG7 pathway.

学科与关键词

关键词
MicroRNA-217Neurofibromatosis type 1Breast cancerChemoresistanceProliferationMigrationAutophagy
相关
加载中…
  • Role of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stem-like cells
    Ke Jia; Zhao Zhiju; Hong Su Hyung; Bai Shoumin; He Zhen; Malik Fayaz; Xu Jiahui; Zhou Lei; Chen Weilong; Martin Trevino Rachel; Wu Xiaojian; Lan Ping; Yi Yongju; Ginestier Christophe; Ibarra Ingrid; Shang Li; McDermott Sean; Luther Tahra; Clouthier Shawn G; Wicha Max S; Liu Suling*ONCOTARGET, 2015, 6(6): 3709-3721.被引 5
  • MiR-491-5p, as a Tumor Suppressor, Prevents Migration and Invasion of Breast Cancer by Targeting ZNF-703 to Regulate AKT/mTOR Pathway
    Guo, Jingyun; Luo, Can; Yang, Yuqin; Dong, Jianyu; Guo, Zhaoze; Yang, Jinlamao; Lian, Huining; Ye, Changsheng*; Liu, Minfeng*Cancer Management and Research, 2021, 13: 403-413.被引 18
  • Targeting of TLE3 by miR-3677 in human breast cancer promotes cell proliferation, migration and invasion
    Peng, Li-Na; Deng, Xing-Yan; Gan, Xiao-Xiong; Zhang, Jin-Hui; Ren, Guang-Hui; Shen, Fei; Feng, Jian-Hua; Cai, Wen-Song; Xu, Bo*Oncology Letters, 2020, 19(2): 1409-1417.被引 14
查看全部 →

发表信息

论文状态
公开发表
期刊
Human Cell
发表日期
2023-01
卷期
第 36 卷, 第 1 期
页码
377-392
DOI
10.1007/s13577-022-00817-y
语言
ENGLISH
成果收录
SCIE
资助标注
Bao'an District Traditional Chinese Medicine Development Foundation [2020KJCX-KTYJ-12]; Shenzhen Bao'an District Hospital of Traditional Chinese Medicine Pi Team Project [BAZYY20200601]; Shenzhen Bao'an District Acupuncture Clinical Research Center [BAZJ2018239]

作者

  • L

    Li, Weihan (第一作者)

  • Y

    Yang, Chaojie

    2 · guangzhou univ chinese med

查看全部 5 位作者收起作者
  • L

    Li, Jingjing

  • L

    Li, Xiaolian

  • Z

    Zhou, Peng (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417